Liver transplants are becoming a new treatment option for certain colorectal cancer patients whose cancer has spread to their ...

Real world data show that immunotherapy leads to better overall survival outcomes than chemotherapy in patients with ...

The report forecasts global market growth from $116.1 billion in 2024 to $168 billion by 2029 at a CAGR of 7.7%. Highlighting advances in immunothera ...

The following is a summary of "Proteomic profiling and functional analysis of extracellular vesicles from ...

Merus leads biotech with its innovative antibody platforms, strong financials, and promising petosemtamab targeting cancer.

Alysun Zwanzig, a 25-year-old mother of two, was diagnosed with stage four metastatic colorectal cancer while pregnant, and ...

A phase 2 trial will evaluate leronlimab’s safety and efficacy for the treatment of patients with microsatellite stable ...

Colorectal cancer is the fourth-most-common cancer in the U.S. and the second deadliest. One in 5 patients is diagnosed with ...

By 2023, approximately 1 in 5 patients with non-small cell lung cancer or metastatic colorectal cancer were treated with a bevacizumab biosimilar.